Clinical trial
Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea
NCT07264998
Study timeline
Study start (actual)2025-12-21Date precision: day
Registry last updated2026-04-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Neoplasmsunresolved
Hormone Receptor-Positive Breast Cancerunresolved
Abemaciclibunresolved
Abemaciclib-related Diarrheaunresolved
Drug-induced Diarrheaunresolved
Gastrointestinal Microbiome (Focus)unresolved
Microbiomeunresolved
Interventions
Sponsors & collaborators
Hubei Cancer Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07264998 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.